HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yin, L. Articles by Tuohy, V. K. Search for Related Content PubMed PubMed Citation Articles by Yin, L. Articles by Tuohy, V. K. Pubmed/NCBI databases Substance via MeSH

Pre-Emptive Targeting of the Epitope Spreading Cascade with Genetically Modified Regulatory T Cells During Autoimmune Demyelinating Disease¹

Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195

Epitope spreading or endogenous self-priming has been implicated in mediating the progression of autoimmune disease. In the present study we created an immune-deviated, epitope spreading response in SWXJ mice after the onset of experimental autoimmune encephalomyelitis, a prototypic autoimmune animal model widely used in multiple sclerosis research. We established an immunoregulatory spreading repertoire by transferring T cells genetically modified to produce high levels of IL-10 in response to a dominant epitope spreading determinant. Installation of a Th2/Tr1-like spreading repertoire resulted in a marked and prolonged inhibition of disease progression and demyelination characterized by 1) bystander inhibition of the recall response to the priming immunogen, and 2) a Th1Tr1 immune-deviated spreading response involving a shift in the source of IL-10 production from the transferred regulatory population to the host-derived, endogenously primed repertoire. Thus, our data provide a rationale for cell-based therapeutic intervention in multiple sclerosis by showing that pre-emptive targeting of the epitope spreading cascade with regulatory T cells effectively induces an immune-deviated spreading response capable of inhibiting ongoing inflammatory autoreactivity and disease progression.

This article has been cited by other articles:

				J. Tian and D. L. Kaufman Antigen-Based Therapy for the Treatment of Type 1 Diabetes Diabetes, September 1, 2009; 58(9): 1939 - 1946. [Full Text] [PDF]

				D. Castelletti and M. Colombatti Peptide analogues of a T-cell epitope of ricin toxin A-chain prevent agonist-mediated human T-cell response Int. Immunol., April 1, 2005; 17(4): 365 - 372. [Abstract] [Full Text] [PDF]

				V. P. Yeung, J. Chang, J. Miller, C. Barnett, M. Stickler, and F. A. Harding Elimination of an Immunodominant CD4+ T Cell Epitope in Human IFN-{beta} Does Not Result in an In Vivo Response Directed at the Subdominant Epitope J. Immunol., June 1, 2004; 172(11): 6658 - 6665. [Abstract] [Full Text] [PDF]

				R. E. Jones, D. Bourdette, N. Moes, A. Vandenbark, A. Zamora, and H. Offner Epitope Spreading Is Not Required for Relapses in Experimental Autoimmune Encephalomyelitis J. Immunol., February 15, 2003; 170(4): 1690 - 1698. [Abstract] [Full Text] [PDF]